Abdel-Maksoud, Mohammed S. Hassan, Rasha Mohamed El-Azzouny, Aida Abdel-Sattar Aboul-Enein, Mohamed Nabil Oh, Chang-Hyun 2024-01-19T13:03:31Z 2024-01-19T13:03:31Z 2022-04-03 2021-12 0045-2068 https://pubs.kist.re.kr/handle/201004/115958 A new series of N-(2-((4-(1,3-diphenyl-1H-pyrazol-4-yl)pyridine sulfonamide derivatives 11a-o were designed and synthesized based on our previous works. The new series was tested for its anticancer and anti-inflammatory effects. The anticancer profile of final target compounds was obtained by testing them over 60 cell lines belong to nine types of cancers. Compound 11c showed the highest percent inhibition, so its potency was measured over the most sensitive cell line to determine its IC50 over each cell. In addition, compound 11c was tested over kinase panel to get its biological target(s). Compound 11c had strong activity over JNK1, JNK2, p38a and V600EBRAF. All final target compounds were tested against the four kinases to build a structure activity relationship. Compound 11c was subjected to cell cycle analysis to check at which phase is affected by 11c. The anti-inflammatory effect of final target compounds was screened by testing their ability to inhibit both nitric oxide release and prostaglandin E2 production on raw 264.7 macrophages in addition to test their cytotoxic effect on the same cells. Compound 11n showed the highest ability to inhibit prostaglandin E2 and all compound showed moderate to low activity regarding inhibition of nitric oxide release. Compound 11n was investigated for its ability to reduce Interleukin 6 and TNF-alpha. In addition, compound 11n was tested for its effect on induced Nitric oxide synthase (iNOS), and COX-2 mRNA expression level and its effect on nitric oxide synthase (iNOS), COX-1 and COX-2 protein levels where it showed selectivity for COX-2 compared to COX-1 and iNOS. English ACADEMIC PRESS INC ELSEVIER SCIENCE IN-VITRO BIOLOGICAL EVALUATION TYROSINE KINASES INHIBITORS DESIGN RAF DISCOVERY TARGETS EXPRESSION SORAFENIB Anticancer profile and anti-inflammatory effect of new N-(2-((4-(1,3-diphenyl-1H-pyrazol-4-yl)pyridine sulfonamide derivatives Article 10.1016/j.bioorg.2021.105424 1 BIOORGANIC CHEMISTRY, v.117 BIOORGANIC CHEMISTRY 117 scie scopus 000729835300010 2-s2.0-85117369981 Biochemistry & Molecular Biology Chemistry, Organic Biochemistry & Molecular Biology Chemistry Article IN-VITRO BIOLOGICAL EVALUATION TYROSINE KINASES INHIBITORS DESIGN RAF DISCOVERY TARGETS EXPRESSION SORAFENIB Anticancer Anti-inflammatory Kinase inhibitor Pyrazole Sulfonamide